Clinical Trial Update: HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 1/Phase 2 clinical trial evaluating HepaSphere interventional therapy using DSA for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HepaSphere

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED